B cell-derived IL-27 promotes control of persistent LCMV infection

27Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Recent studies have identified a critical role for B cell-produced cytokines in regulating both humoral and cellular immunity. Here, we show that B cells are an essential source of interleukin-27 (IL-27) during persistent lymphocytic choriomeningitis virus (LCMV) clone 13 (Cl-13) infection. By using conditional knockout mouse models with specific IL-27p28 deletion in B cells, we observed that B cell-derived IL-27 promotes survival of virus-specific CD4 T cells and supports functions of T follicular helper (Tfh) cells. Mechanistically, B cell-derived IL-27 promotes CD4 T cell function, antibody class switch, and the ability to control persistent LCMV infection. Deletion of IL-27ra in T cells demonstrated that T cell-intrinsic IL-27R signaling is essential for viral control, optimal CD4 T cell responses, and antibody class switch during persistent LCMV infection. Collectively, our findings identify a cellular mechanism whereby B cell-derived IL-27 drives antiviral immunity and antibody responses through IL-27 signaling on T cells to promote control of LCMV Cl-13 infection.

Cite

CITATION STYLE

APA

Pratumchai, I., Zak, J., Huang, Z., Min, B., Oldstone, M. B. A., & Teijaro, J. R. (2022). B cell-derived IL-27 promotes control of persistent LCMV infection. Proceedings of the National Academy of Sciences of the United States of America, 119(3). https://doi.org/10.1073/pnas.2116741119

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free